Stenosis
is a medical condition that refers to the narrowing of the opening of the
heart's arteries which causes a blood clot to form in the heart. This medical
condition can be caused by a variety of medical conditions, including heart
valve diseases, fatty buildup in the coronary arteries, atherosclerosis, and
other disorders. When this occurs, the blood flow through the heart becomes
very limited and the patient experiences chest pain and shortness of breath.
Because of these symptoms, angioplasty or surgical heart bypass are mostly
recommended. However, not all patients who would need to undergo such
treatments are ideal candidates for this procedure.
Sternal
closure systems are the final step in cardiac surgeries and are utilized to
close the mitral valve, which is the uppermost dilation of the heart's aortic
valve. This method involves steel screws that are placed on both sides of the
mitral valve to close it tightly. Cardiac insufficiency is a condition where
the heart is unable to pump enough blood to supply for a healthy body. In order
to prevent excessive blood clots from forming in the cardiac arteries, it is
necessary that you have proper cardiac fibrillation control. Sternal
closure systems are widely used to treat cardiac-related problems.
The
global sternal systems market has experienced a number of technological
innovations over the past few years, thanks to the introduction of medical electronic
devices. One of the most interesting trends in the medical devices and
equipment market includes the growing availability of medical reimbursements
across the world. The United States and the UK offer medical reimbursements of
nearly 80 percent of a patient's expenses.
Recently,
a US based company, Zimmer Biomet has announced the acquisition of A&E
Medical Corporation, a Vance Street Capital Portfolio Company, and its sternal
closure portfolio
Comments
Post a Comment